FDA Finds Traces Of Probable Carcinogen In Some Heartburn Drugs

The FDA released a statement about low levels of NDMANDMA, a probable carcinogen, found in some medicines, including Zantac. The FDA is investigating the potential risks of MDMA in ranitidine but does not currently advise users to stop taking it. Alternatives are available for those who prefer to avoid ranitidine.

What is the FDA evaluating in relation to the low levels of MDMA in ranitidine?

Evaluate responses using AI:

OFF

What alternative options does the FDA suggest for those who want to avoid Ranitidine?

Evaluate responses using AI:

OFF